Graft-mediated hybridisation of monocotyledonous plants

US2022015311A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022015311-A1
Application numberUS-201917293765-A
CountryUS
Kind codeA1
Filing dateNov 14, 2019
Priority dateNov 14, 2018
Publication dateJan 20, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to the production of graft-mediated hybrid monocotyledonous plants. Methods for the production of such plants are disclosed herein.

First claim

Opening claim text (preview).

1 . A method of producing a hybrid monocot tissue or plant, comprising: (a) providing a first tissue comprising: (i) mesocotyl and radicle tissue; or (ii) mesocotyl and plumule tissue of a first monocot plant, wherein said first tissue comprises in its genome a first marker; (c) providing a second tissue comprising: (i) mesocotyl and radicle tissue; or (ii) mesocotyl and plumule tissue of a second, different monocot plant, wherein said second tissue comprises in its genome a second, different marker; (c) placing said first tissue in contact with said second tissue; (d) allowing fusion of the first and second tissues such that a graft junction forms, wherein said graft junction comprises at least one hybrid cell comprising said first and second markers; (e) selecting said at least one hybrid cell based on the presence of said first and second markers; and (f) regenerating a hybrid monocot tissue or plant from said at least one hybrid cell. 2 . The method of claim 1 , wherein said first tissue comprises mesocotyl and plumule tissue and said second tissue comprises mesocotyl and radicle tissue. 3 . The method of claim 1 or 2 , wherein after step (d) and before step (e), said graft junction is cut to provide at least one longitudinal graft junction section, wherein said graft junction section comprises said at least one hybrid cell comprising said first and second markers. 4 . The method of any one of claims 1 to 3 , wherein said first marker and/or said second marker is a selectable marker, wherein said selectable marker is selectable with a selection agent. 5 . The method of any one of claims 1 to 4 , wherein said first marker and/or said second marker is a visual marker; preferably wherein said visual marker is: (i) a fluorescent marker; (ii) GUS; or (iii) luciferase 6 . The method of any one of claims 1 to 5 , wherein said first marker and/or said second marker is an endogenous trait, wherein said endogenous trait is not endogenous to both the first tissue and the second tissue; preferably wherein said endogenous trait confers: (i) salinity tolerance; (ii) chilling tolerance; (iii) freezing tolerance; (iv) heavy metal detoxification; (v) explosive detoxification; or (vi) the ability to metabolise mannose, xylose or benzyladenine-N-3-glucuronide. 7 . The method of any one of claims 1 to 4 , wherein said first marker and said second marker are selectable markers, wherein said first selectable marker is selectable with a first selection agent and said second selectable marker is selectable with a second, different selection agent. 8 . The method of claim 4 or 7 , wherein said first selection agent and/or said second selection agent comprises: (i) an antibiotic; (ii) a herbicide; (iii) a toxin; (iv) salt; or (v) a sugar. 9 . The method of claim 8 , wherein: (i) said antibiotic is selected from the group consisting of: kanamycin, geneticin (G418), hygromycin, paramomycin, neomycin, spectinomycin, streptomycin, gentamicin, tobramycin, apramycin, bleomycin, phleomycin, streptothricin, and/or chloramphenicol; (ii) said herbicide is selected from the group consisting of: glyphosate, glufosinate (or phosphinothricin/BASTA), bialaphos, chlorsulfuron, 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), atrazine, paraquot, methyl viologen, metsulfuron-methyl, triclopyr, 3-Amino-1,2,4-triazole (3-AT), a sulfonylurea, an imidazolinone, a triazolopyrimidine, a pyrimidinyl oxybenzoate, and/or a sulfonylamino carbonyl triazolinone; (iii) said toxin is selected from the group consisting of: 2-deoxyglucose, thialysine, methotrexate, cyanamide, sodium hypochloride, gabaculine, 4-methyl tryptophan, and/or glycine betaine aldehyde; and/or (iv) said sugar is selected from the group consisting of: mannose, xylose and benzyladenine-N-3-glucuronide. 10 . The method of any one of claims 7 to 9 , wherein said regenerating comprises: (i) placing said graft junction or graft junction section on a base medium comprising at least one auxin, at least one cytokinin and said first and second selection agents; preferably for one month to one year; such that hybrid tissue forms from said hybrid cell; and optionally (ii) placing said hybrid tissue on a shooting medium; preferably for one to two months; such that at least one hybrid shoot forms from said hybrid tissue; and further optionally (iii) placing said hybrid shoot on rooting medium; preferably for two to four weeks; such that at least one hybrid monocot plant comprising roots forms; and further optionally (iv) transferring said hybrid monocot plant to soil. 11 . The method of any one of claims 1 to 10 , wherein the first tissue and/or the second tissue are provided: (i) from a first seed and a second seed; and/or (ii) by micropropagation in tissue culture. 12 . The method of claim 11 , wherein said first seed and/or said second seed comprises its seed coat. 13 . The method of claim 11 or 12 , wherein said first seed and/or said second seed: (i) is dry or imbibed in water; preferably imbibed in water for 8 to 72 hours; and/or (ii) is partially germinated in the dark; preferably for 4 to 30 days. 14 . The method of claim 11 or 12 , wherein said first seed is imbibed in water; preferably for 8to 72 hours; and said second seed is dry. 15 . The method of any one of claims 11 to 14 , wherein: (i) said first and/or said second seed is transversely cut; preferably with a razor or other straight blade; more preferably wherein the razor blade is 0.1 to 0.2 mm thick; and/or (ii) said first and/or said second seed is cut with a tissue puncher; preferably wherein the tissue puncher is 1.2 mm in diameter and comprises a cutting edge with a thickness of 0.1 to 0.3 mm. 16 . The method of any one of claims 11 to 15 , wherein the first tissue and/or the second tissue is tissue cultured on nutrient medium containing a cytokinin; preferably wherein the cytokinin is: (i) N 6 -benzyladenine (BAP); (ii) kinetin; (iii) zeatin; (iv) dihydrozeatin; (v) thidiazuron (TDZ); (vi) diphenylurea; (vii) 6-benzylamino-9-(2-tetrahydropyranyl)-9H-purine (BPA); (viii) forchlorfenuron; or (ix) N 6 -isopentenyladenine (2iP). 17 . The method of any one of claims 1 to 16 , wherein the first tissue and the second tissue are from the same species. 18 . The method of any one of claims 1 to 16 , wherein the first tissue and the second tissue are from different species within the same order. 19 . The method of claim 18 , wherein either one of the first tissue and the second tissue is from a C 3 plant and the other one is from a C 4 plant; preferably wherein the C 3 plant is selected from the group consisting of: bread wheat ( Triticum aestivum ) and rice ( Oryza sativa ) and/or the C 4 plant is selected from the group consisting of: pearl millet ( Pennisetum glaucum ), sorghum ( Sorghum bicolor ) and maize ( Zea mays ); more preferably wherein the trait of C 4 photosynthesis is conferred to the regenerated hybrid monocot tissue or plant. 20 . The method of claim 18 , wherein either one of the first tissue and the second tissue is: (i) from a salinity tolerant plant and the other is from a salinity intolerant plant; preferably wherein the salinity tolerant plant is selected from the group consisting of: Oryza coarctata, sea barley grass ( Hordeum marinum ) and tall wheatgrass ( Thinopyrum ponticum or Agropyron elongatum ) and/or the salinity intolerant plant is selected from the group consisting of: rice (

Assignees

Inventors

Classifications

  • A01H1/06Primary

    Processes for producing mutations, e.g. treatment with chemicals or with radiation (specific mutations prepared by genetic engineering on plant cell or plant tissues C12N15/00 {; process for producing transgenic plants C12N15/82}) · CPC title

  • Triticum sp. [wheat] · CPC title

  • Oryza sp. [rice] · CPC title

  • Pennisetum [pearl millet] · CPC title

  • Hordeum vulgarus [barley] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022015311A1 cover?
The invention relates to the production of graft-mediated hybrid monocotyledonous plants. Methods for the production of such plants are disclosed herein.
Who is the assignee on this patent?
Cambridge Entpr Ltd
What technology area does this patent fall under?
Primary CPC classification A01H1/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).